{"votes": [{"model": "llama3.2", "created_at": "2024-12-13T00:54:18.390168152Z", "message": {"role": "assistant", "content": "I can see that the abstract discusses a clinical trial comparing immunomodulatory drug-containing regimens for patients with relapsed or refractory multiple myeloma. The focus is on treatment efficacy, particularly for patients who are suitable candidates for immunomodulatory drug (IMiD)-containing regimens.\n\nHowever, I don't see any mention of wireless mesh networks, ad-hoc networks, IoT, autonomous robots, industrial applications, routing protocols, or fault tolerance, which are the key concepts mentioned in the scoping review context. The abstract appears to be focused on clinical efficacy and treatment outcomes for patients with multiple myeloma.\n\nIn conclusion, the answer is no."}, "done_reason": "stop", "done": true, "total_duration": 24127435035, "load_duration": 17225072, "prompt_eval_count": 656, "prompt_eval_duration": 14571000000, "eval_count": 137, "eval_duration": 9535000000, "verdict": false}, {"model": "llama3.2", "created_at": "2024-12-13T00:54:27.358093147Z", "message": {"role": "assistant", "content": "Reasoning:\nThis abstract discusses a network meta-analysis on immunomodulatory drug-containing regimens for relapsed or refractory multiple myeloma patients, focusing on the clinical efficacy of daratumumab plus lenalidomide and dexamethasone (DRd). The study found that DRd was significantly better than other IMiD-containing regimens in improving progression-free survival and overall response. However, there is no mention of wireless mesh networks, ad-hoc networks, IoT, autonomous robots, or industrial applications, which are the focus of the scoping review.\n\nIn conclusion, the answer is No."}, "done_reason": "stop", "done": true, "total_duration": 8966237849, "load_duration": 17239650, "prompt_eval_count": 656, "prompt_eval_duration": 68000000, "eval_count": 127, "eval_duration": 8877000000, "verdict": false}, {"model": "llama3.2", "created_at": "2024-12-13T00:54:35.614233836Z", "message": {"role": "assistant", "content": "Reasoning:\n\nThis study focuses on multiple myeloma treatment regimens using immunomodulatory drugs (IMiDs), which is outside the scope of the scoping review that aims to investigate the clinical efficacy of routing protocols for wireless mesh networks, particularly in IoT, autonomous robots, and similar industrial applications. The abstract discusses a systematic review and network meta-analysis comparing different IMiD-containing regimens for patients with relapsed or refractory multiple myeloma, which does not relate to the scoping review's objectives.\n\nConclusion: \nIn conclusion, the answer is no."}, "done_reason": "stop", "done": true, "total_duration": 8254561003, "load_duration": 17419865, "prompt_eval_count": 656, "prompt_eval_duration": 69000000, "eval_count": 117, "eval_duration": 8164000000, "verdict": false}], "verdict": false}